Effect of Pycnogenol Supplementation on Blood Pressure: A Systematic Review and Meta-analysis

Overview

Journal Iran J Public Health

Date 2018 Aug 9

PMID 30087862

Citations 4

Authors

Zheng Zhang

Xing Tong

Yu-Lu Wei

Lin Zhao

Jia-Ying Xu

Li-Qiang Qin

Affiliations

Soon will be listed here.

Abstract

Background: Pycnogenol exhibits many biological activities, including control of blood pressure (BP). However, the reported results are inconsistent because of varied characteristics of participants and quality of studies. Thus, a meta-analysis was conducted to examine the effect of Pycnogenol supplementation on BP.

Methods: This literature search of PubMed, the Web of Science and the Cochrane library was performed in May 2016 to identify eligible studies. Reference lists of the retrieved articles were also reviewed. Either a fixed-effects or, in the presence of heterogeneity, a random-effects model was used to calculate the effect of combined treatment.

Results: We identified nine trials involving 549 participants who received Pycnogenol supplementation ranging from 150 mg/d to 200 mg/d. Compared with the control, the pooled estimate of change in systolic and diastolic BPs were -3.22 mmHg (95% CI: -6.20, -0.24) and -3.11 mmHg (95% CI: -4.60, -1.62), respectively. Subgroup analyses showed higher BP reduction among hypertensive participants or those who received intervention for more than 12 wk. However, this significant reduction was not observed in well-designed trials.

Conclusion: This meta-analysis with nine trials provides better evidence that Pycnogenol exerts beneficial effects on BP.

Citing Articles

Does supplementation with pine bark extract improve cardiometabolic risk factors? A systematic review and meta-analysis.

Mohammadi S, Fulop T, Khalil A, Ebrahimi S, Hasani M, Ziaei S BMC Complement Med Ther. 2025; 25(1):71.

PMID: 39987124 PMC: 11847364. DOI: 10.1186/s12906-025-04819-9.

Protective Effect of Pycnogenol against Methotrexate-Induced Hepatic, Renal, and Cardiac Toxicity: An In Vivo Study.

Al-Abkal F, Abdel-Wahab B, Abd El-Kareem H, Moustafa Y, Khodeer D Pharmaceuticals (Basel). 2022; 15(6).

PMID: 35745592 PMC: 9229807. DOI: 10.3390/ph15060674.

The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial.

Qorbani M, Sanginabadi M, Mohajeri-Tehrani M, Karimi S, Gerami H, Mahdavi-Gorabi A Front Endocrinol (Lausanne). 2021; 11:590392.

PMID: 33408691 PMC: 7779998. DOI: 10.3389/fendo.2020.590392.

Pine bark (Pinus spp.) extract for treating chronic disorders.

Robertson N, Schoonees A, Brand A, Visser J Cochrane Database Syst Rev. 2020; 9:CD008294.

PMID: 32990945 PMC: 8094515. DOI: 10.1002/14651858.CD008294.pub5.

Evaluation of the effects of pycnogenol (French maritime pine bark extract) supplementation on inflammatory biomarkers and nutritional and clinical status in traumatic brain injury patients in an intensive care unit: A randomized clinical trial....

Malekahmadi M, Moghaddam O, Islam S, Tanha K, Nematy M, Pahlavani N Trials. 2020; 21(1):162.

PMID: 32046747 PMC: 7014642. DOI: 10.1186/s13063-019-4008-x.

References

Hage F . C-reactive protein and hypertension. J Hum Hypertens. 2013; 28(7):410-5. DOI: 10.1038/jhh.2013.111. View

Stuard S, Belcaro G, Cesarone M, Ricci A, Dugall M, Cornelli U . Kidney function in metabolic syndrome may be improved with Pycnogenol®. Panminerva Med. 2010; 52(2 Suppl 1):27-32. View

Fitzpatrick D, BING B, Rohdewald P . Endothelium-dependent vascular effects of Pycnogenol. J Cardiovasc Pharmacol. 1998; 32(4):509-15. DOI: 10.1097/00005344-199810000-00001. View

MASQUELIER J, Michaud J, Laparra J, Dumon M . [Flavonoids and pycnogenols]. Int J Vitam Nutr Res. 1979; 49(3):307-11. View

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

Nishioka K, Hidaka T, Nakamura S, Umemura T, Jitsuiki D, Soga J . Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans. Hypertens Res. 2007; 30(9):775-80. DOI: 10.1291/hypres.30.775. View

Belcaro G, Cornelli U, Luzzi R, Cesarone M, Dugall M, Feragalli B . Pycnogenol® supplementation improves health risk factors in subjects with metabolic syndrome. Phytother Res. 2013; 27(10):1572-8. DOI: 10.1002/ptr.4883. View

Higgins J, Thompson S, Deeks J, Altman D . Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. PMC: 192859. DOI: 10.1136/bmj.327.7414.557. View

Hu S, Belcaro G, Cornelli U, Luzzi R, Cesarone M, Dugall M . Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. Int Angiol. 2014; 34(1):43-52. View

10.

Cesarone M, Belcaro G, Rohdewald P, Pellegrini L, Ledda A, Vinciguerra G . Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study. Angiology. 2006; 57(4):431-6. DOI: 10.1177/0003319706290318. View

11.

Weber H, Hodges A, Guthrie J, OBrien B, Robaugh D, Clark A . Comparison of proanthocyanidins in commercial antioxidants: grape seed and pine bark extracts. J Agric Food Chem. 2007; 55(1):148-56. DOI: 10.1021/jf063150n. View

12.

Gulati O . Pycnogenol® in Metabolic Syndrome and Related Disorders. Phytother Res. 2015; 29(7):949-68. DOI: 10.1002/ptr.5341. View

13.

Drieling R, Gardner C, Ma J, Ahn D, Stafford R . No beneficial effects of pine bark extract on cardiovascular disease risk factors. Arch Intern Med. 2010; 170(17):1541-7. DOI: 10.1001/archinternmed.2010.310. View

14.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

15.

Belcaro G, Cesarone M, Errichi S, Zulli C, Errichi B, Vinciguerra G . Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol. Redox Rep. 2008; 13(6):271-6. DOI: 10.1179/135100008X309019. View

16.

Zibadi S, Rohdewald P, Park D, Watson R . Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation. Nutr Res. 2008; 28(5):315-20. DOI: 10.1016/j.nutres.2008.03.003. View

17.

Cesarone M, Di Renzo A, Errichi S, Schonlau F, Wilmer J, Blumenfeld J . Improvement in circulation and in cardiovascular risk factors with a proprietary isotonic bioflavonoid formula OPC-3. Angiology. 2008; 59(4):408-14. DOI: 10.1177/0003319708321801. View

18.

Devaraj S, Vega-Lopez S, Kaul N, Schonlau F, Rohdewald P, Jialal I . Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile. Lipids. 2003; 37(10):931-4. DOI: 10.1007/s11745-006-0982-3. View

19.

Jadad A, Moore R, Carroll D, Jenkinson C, Reynolds D, Gavaghan D . Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996; 17(1):1-12. DOI: 10.1016/0197-2456(95)00134-4. View

20.

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View